 |
 |
 |
|
|
|||
|
|
||||
|
||||
FIBROIDS: Phase III Trials Of PGL4001 In Uterine MyomaFrom: Hope Waltman (anonymous@obgyn.net)Sat, 23 Aug 2008 07:33:17 -0500 (CDT)
PregLem Starts Phase III Trials Of PGL4001 In Uterine Myoma "Phase III clinical trial program for PGL4001 (ulipristal) in symptomatic uterine myoma, a common benign solid tumor of the genital tract in women of reproductive age. PGL4001, an orally active, selective progesterone receptor modulator, was shown in a previous Phase II study to be well tolerated and effective both in immediately stopping uterine bleeding, a major symptom associated with the condition, and in reducing myoma volume. Results of the Phase III trials are expected in 2010. The program is composed of two separate Phase III clinical trials involving a total of 540 patients and being carried out in parallel in a total of 14 countries." http://www.medicalnewstoday.com/articles/118669.php http://www.preglem.com/pages/products.asp Regards, Hope Waltman, Fibroid Forum and WH Forum Moderator http://www.hopeforfibroids.org http://www.doctorsinfoweb.com/doctors.htm UTERINE FIBROIDS INFO: http://www.obgyn.net/fibroid-resource-center/ http://www.obgyn.net/fibroid-resource-center/?page=articles/patient_articles
|
|
Return to ![[ Women's Health Forum ]](http://www.obgyn.net/images_women/wh-forum.gif)
Report TECHNICAL Problems ONLY to: webmaster@obgyn.net
Last Updated: Wed Dec 2 06:55:53 2009
Women's Insurance Checklist from Auto Insurance Quote
home | medical professionals | women | industry | forums | international